New Framework Conditions for Biotech and Life Sciences in the U.S.

Barnes & Thornburg partners Timo Rehbock and Christine Sohar Henter will join an informational webinar on the economic and regulatory landscape in the U.S. and its impact on European biotech and life science companies. The session will cover the U.S. market outlook, opportunities and risks for international startups, shifts in international trade, and key FDA regulatory updates — offering essential insights for health sector companies looking to enter or expand in the world’s most advanced life sciences ecosystem.